Naproxen
- Product NDC
- 0440-7852
- 11-digit product format
- 004407852
- Labeler code
- 0440
- Product ID
- 0440-7852_89ada3cc-d634-43fd-a873-a912d2c9ecd1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Liberty Pharmaceuticals, Inc.
- Application
- ANDA075927
- Marketing category
- ANDA
- Marketing start
- 2010-02-18
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0440-7852-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-939a-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
| 0440-7852-20 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-939a-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
| 0440-7852-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-939a-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
| 0440-7852-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-939a-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0440-7852-14 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 1 | |
| 0440-7852-20 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 1 | |
| 0440-7852-30 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 0440-7852-60 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0440-7852-20 | EA - Each | 0440-7852 | 96d88284-4f5f-4546-a04a-1bba5c2284cd | 1 | 2017-05-03 |
| 0440-7852-30 | EA - Each | 0440-7852 | 5bf459e6-7b1a-4fdc-be32-74633c33890d | 1 | 2017-05-03 |
| 0440-7852-60 | EA - Each | 0440-7852 | 3ef9a783-c2d5-4e28-91c5-301d85d615b5 | 1 | 2015-06-09 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198014 | naproxen 500 MG Oral Tablet | PSN | 4054e004-de40-4e51-bd37-ce9d04eef164 | 1 |
| 198014 | naproxen 500 MG Oral Tablet | SCD | 4054e004-de40-4e51-bd37-ce9d04eef164 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 0440-7852-14 | 00440785214 | 14 in 1 BOTTLE | Historical |
| 0440-7852-20 | 00440785220 | 20 in 1 BOTTLE | Historical |
| 0440-7852-30 | 00440785230 | 30 in 1 BOTTLE | Historical |
| 0440-7852-60 | 00440785260 | 60 in 1 BOTTLE | Historical |